McKinsey 77
Technological development will also be a key stepping stone , opines McKinsey , because the nature of pharmaceutical supply chains has fundamentally altered ; they are “ becoming more patient-centric due to the increased adoption of digital tools , telehealth and app-based ecosystems .” Digital tools such as blockchain and digital twin have the net benefit of increasing transparency and boost a company ’ s ability to accurately forecast demand by assessing contingency situations in a controlled environment in preparation for the actual event .
healthcareglobal . com